The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.
ARK Genomic Revolution ETF (ARKG) trades at $47.87, down 3.97% on the day, as of Oct 23, 2026 00:44 UTC.
ARK Genomic Revolution ETF has a market capitalisation of $1.67B, calculated from the live ARKG share price and shares outstanding.
ARK Genomic Revolution ETF generated revenue of $0.00 over the trailing twelve months.
ARKG has traded between $24.60 and $58.83 over the past 52 weeks, and the last price is 18.6% below that high.
ARK Genomic Revolution ETF is classified under the Financial Services sector and the Asset Management industry, and is domiciled in US.
QFI Terminal shows ARKG with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ARKG in Terminal See plans